Tcw Group Inc Novo Nordisk A S Transaction History

Tcw Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$46.36 - $52.63 $1.49 Million - $1.69 Million	-32,050 Closed	0 $0
Q3 2018 Oct 30, 2018	BUY	$46.76 - $51.24 $409,150 - $448,350	8,750 Added 37.55%	32,050 $1.51 Million
Q1 2018 May 11, 2018	BUY	$48.49 - $58.14 $72,735 - $87,210	1,500 Added 6.88%	23,300 $1.15 Million
Q2 2017 Aug 11, 2017	BUY	N/A	21,800	21,800 $935,000

1,953

320M

5.39M

5.46M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $241B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

Stay updated on Tcw Group Inc with notifications on news.